Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:18401239rdf:typepubmed:Citationlld:pubmed
pubmed-article:18401239lifeskim:mentionsumls-concept:C0043210lld:lifeskim
pubmed-article:18401239lifeskim:mentionsumls-concept:C0086839lld:lifeskim
pubmed-article:18401239lifeskim:mentionsumls-concept:C0000768lld:lifeskim
pubmed-article:18401239lifeskim:mentionsumls-concept:C0086045lld:lifeskim
pubmed-article:18401239lifeskim:mentionsumls-concept:C0389071lld:lifeskim
pubmed-article:18401239lifeskim:mentionsumls-concept:C0311400lld:lifeskim
pubmed-article:18401239lifeskim:mentionsumls-concept:C0021655lld:lifeskim
pubmed-article:18401239lifeskim:mentionsumls-concept:C2699787lld:lifeskim
pubmed-article:18401239pubmed:issue2lld:pubmed
pubmed-article:18401239pubmed:dateCreated2008-4-10lld:pubmed
pubmed-article:18401239pubmed:abstractTextThe authors compared postpartum adiponectin levels among women with prior pregnancy-induced disturbances and assessed their association with homeostasis model assessment for insulin resistance (HOMA-IR), the metabolic syndrome (MS), and the Framingham risk score (FRS). Women delivering in 1998 through 2001 and who had gestational diabetes mellitus (n=22), gestational hypertension (n=32), or preeclampsia (n=34) were examined 1 to 2 years after delivery and were grouped-matched to controls (n=29) by age and prepregnancy body mass index. HOMA-IR was increased, adiponectin values were decreased, and there was a higher MS prevalence in women with prior gestational diabetes mellitus (all P<.05). Adiponectin levels were inversely related to HOMA-IR (r=-0.45; P<.0001) and FRS (r=-0.25; P=.007), and a significant trend for decreasing adiponectin values with increased number of MS components was noted (P trend <.0001). Adiponectin concentration remained a significant correlate of FRS and MS irrespective of pregnancy history; a concentration <10.5 microg/mL provided the optimal cutoff to distinguish those with or without MS. Thus, a lower postpartum adiponectin concentration identifies women at increased cardiovascular risk regardless of pregnancy history.lld:pubmed
pubmed-article:18401239pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18401239pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18401239pubmed:languageenglld:pubmed
pubmed-article:18401239pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18401239pubmed:citationSubsetIMlld:pubmed
pubmed-article:18401239pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18401239pubmed:statusMEDLINElld:pubmed
pubmed-article:18401239pubmed:issn1520-037Xlld:pubmed
pubmed-article:18401239pubmed:authorpubmed-author:OrchardTrevor...lld:pubmed
pubmed-article:18401239pubmed:authorpubmed-author:MarkovicNinaNlld:pubmed
pubmed-article:18401239pubmed:authorpubmed-author:CostacouTinaTlld:pubmed
pubmed-article:18401239pubmed:authorpubmed-author:BosnyakZsoltZlld:pubmed
pubmed-article:18401239pubmed:authorpubmed-author:HargerGail...lld:pubmed
pubmed-article:18401239pubmed:authorpubmed-author:SilversNancyNlld:pubmed
pubmed-article:18401239pubmed:issnTypePrintlld:pubmed
pubmed-article:18401239pubmed:volume11lld:pubmed
pubmed-article:18401239pubmed:ownerNLMlld:pubmed
pubmed-article:18401239pubmed:authorsCompleteYlld:pubmed
pubmed-article:18401239pubmed:pagination106-15lld:pubmed
pubmed-article:18401239pubmed:meshHeadingpubmed-meshheading:18401239...lld:pubmed
pubmed-article:18401239pubmed:meshHeadingpubmed-meshheading:18401239...lld:pubmed
pubmed-article:18401239pubmed:meshHeadingpubmed-meshheading:18401239...lld:pubmed
pubmed-article:18401239pubmed:meshHeadingpubmed-meshheading:18401239...lld:pubmed
pubmed-article:18401239pubmed:meshHeadingpubmed-meshheading:18401239...lld:pubmed
pubmed-article:18401239pubmed:meshHeadingpubmed-meshheading:18401239...lld:pubmed
pubmed-article:18401239pubmed:meshHeadingpubmed-meshheading:18401239...lld:pubmed
pubmed-article:18401239pubmed:meshHeadingpubmed-meshheading:18401239...lld:pubmed
pubmed-article:18401239pubmed:meshHeadingpubmed-meshheading:18401239...lld:pubmed
pubmed-article:18401239pubmed:meshHeadingpubmed-meshheading:18401239...lld:pubmed
pubmed-article:18401239pubmed:meshHeadingpubmed-meshheading:18401239...lld:pubmed
pubmed-article:18401239pubmed:meshHeadingpubmed-meshheading:18401239...lld:pubmed
pubmed-article:18401239pubmed:meshHeadingpubmed-meshheading:18401239...lld:pubmed
pubmed-article:18401239pubmed:meshHeadingpubmed-meshheading:18401239...lld:pubmed
pubmed-article:18401239pubmed:year2008lld:pubmed
pubmed-article:18401239pubmed:articleTitlePostpartum adiponectin concentration, insulin resistance and metabolic abnormalities among women with pregnancy-induced disturbances.lld:pubmed
pubmed-article:18401239pubmed:affiliationUniversity of Pittsburgh, Department of Epidemiology, Pittsburgh, PA 15213, USA. costacout@edc.pitt.edulld:pubmed
pubmed-article:18401239pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:18401239pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:18401239pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:18401239pubmed:publicationTypeResearch Support, N.I.H., Extramurallld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18401239lld:pubmed